International Patent: SOLID FORMS OF 1-(4-(4-((3-(3,6-DIFLUOROPYRIDIN-2-YL)-1-((1R,4R)-4-ETHOXYCYCLOHEXYL)-1H-PYRAZOL-4-YL) CARBAMOYL)THIAZOL-2-YL)-1H-PYRAZOL-1-YL)ETHYL PHOSPHATE AND SALTS THEREOF, AND THEIR PHARMACEUTICAL COMPOSITIONS AND USES

GENEVA, June 26 -- RIGEL PHARMACEUTICALS, INC. filed a patent application (US2025/058337) for “SOLID FORMS OF 1-(4-(4-((3-(3,6-DIFLUOROPYRIDIN-2-YL)-1-((1R,4R)-4-ETHOXYCYCLOHEXYL)-1H-PYRAZOL-4-YL) CARBAMOYL)THIAZOL-2-YL)-1H-PYRAZOL-1-YL)ETHYL PHOSPHATE AND SALTS THEREOF, AND THEIR PHARMACEUTICAL COMPOSITIONS AND USES”. With publication no. WO/2026/122925, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07F 9/6558

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....